NDC 10122-141

Retavase

Reteplase

Retavase is a Kit in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is .

• Product ID: 10122-141_401c47cc-bb82-40e1-a77a-9783c5fc92f2
• NDC: 10122-141
• Product Type: Human Prescription Drug
• Proprietary Name: Retavase
• Generic Name: Reteplase
• Dosage Form: Kit
• Marketing Start Date: 1996-10-30
• Marketing Category: BLA / BLA
• Application Number: BLA103786
• Labeler Name: Chiesi USA, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 10122-141-02

1 KIT in 1 BOX (10122-141-02) * 10 mL in 1 VIAL, SINGLE-USE * 10 mL in 1 SYRINGE (10122-142-01)

• Marketing Start Date: 1996-10-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 10122-141-02 [10122014102]

Retavase KIT

• Marketing Category: BLA
• Application Number: BLA103786
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-10-30

Drug Details

OpenFDA Data

• SPL SET ID: e7b63b16-d911-478b-a445-b690a1360b48
• Manufacturer:
  • Chiesi USA, Inc.
• RxNorm Concept Unique ID - RxCUI:
  • 763141
  • 763138

NDC Crossover Matching brand name "Retavase" or generic name "Reteplase"

NDC	Brand Name	Generic Name
10122-141	Retavase	reteplase
10122-143	Retavase	reteplase